Statins Might Inhibit Prostate Cancer from Invading Bones
One of the more recent conversations surrounding prostate cancer treatment that we have been hearing involves the use of the anti-cholesterol drugs or statins. The conversation, whether or not statins might be a good treatment [...]
A Surprising Biochemical Response to Ketoconazole In Post-Chemotherapy mCRPC Men When Compared to the Zytiga Trial Results
It has always been assumed that Ketoconazole, when used for the treatment of men with metastatic castration resistant prostate cancer (mCRPC), would not be as potent as abiraterone (Zytiga), but there has never been any [...]
NICE Recommends Xtandi for Men with Prior Zytiga Exposure – Good News for our Brothers and Ammunition to Appeal Step Therapy
There is some really good news for those of us who live in areas where The National Institute for Health and Care Excellence (NICE) recommends drug approvals. NICE has issued a final draft guidance recommending [...]
Really, Yes, Alternative Digit Ratios Might Be A Reliable Predictor of Prostate Cancer Aggressiveness As Well As Speak to Racial Disparities
There are occasional conversations about the possibility of looking at a man’s fingers and predicting the aggressiveness of their prostate cancer. Is this real science or is this voodoo science? This might actually be real [...]
Xtandi Receives an FDA Review Date for Pre-Chemotherapy Use
It comes without any great surprise, but earlier in the month the FDA announced they were giving the application from Astellas and Medivation for a priority review to extend the indication (FDA approved use) for [...]
Just One Year On Androgen Deprivation (ADT) Creates Significant Lipid and Glucose Metabolism Problems
It is a widely understood that androgen deprivation therapy (ADT) causes adverse side effects and events. Some researchers believe that the ADT-induced alterations in lipid and glucose metabolism may be race-dependent. To evaluate this concern [...]